These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30054)

  • 41. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.
    Freeman H; Mehta IS
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309
    [No Abstract]   [Full Text] [Related]  

  • 42. [Long-latency auditory evoked responses in Parkinson disease and in parkinsonism induced by neuroleptics].
    Jacquy J; Mettens P; Blum S; Jacqmotte N; Vanderheyden JE
    Acta Neurol Belg; 1993; 93(3):119-29. PubMed ID: 8102219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between structure and drug-induced parkinsonism.
    Sawada Y; Nasu R; Matsuo H; Ohtani H
    Ann Pharmacother; 2000 May; 34(5):668. PubMed ID: 10852100
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 46. Update on Parkinson disease.
    Lieberman AN
    N Y State J Med; 1987 Mar; 87(3):147-53. PubMed ID: 3472111
    [No Abstract]   [Full Text] [Related]  

  • 47. Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease.
    Nakashima K; Shimoda M; Kuno N; Takahashi K
    Mov Disord; 1994 Jan; 9(1):106-7. PubMed ID: 8139589
    [No Abstract]   [Full Text] [Related]  

  • 48. [Neuroleptic parkinsonism].
    Izakson KhA
    Med Sestra; 1986 Sep; 45(9):50-2. PubMed ID: 2880275
    [No Abstract]   [Full Text] [Related]  

  • 49. [The effect of phenamine on medicinal parkinsonism and retardation of movement upon stimulation of the caudate nucleus (a clinico-experimental study)].
    Arushanian EB; Stoliarov GV; Tolpyshev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(9):1384-8. PubMed ID: 5511122
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic progress--review XX. Drug treatment of Parkinson's disease.
    Pall HS; Williams AC; Ramsden DB
    J Clin Hosp Pharm; 1986 Aug; 11(4):229-36. PubMed ID: 3531240
    [No Abstract]   [Full Text] [Related]  

  • 51. Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
    Preskorn SH
    J Psychiatr Pract; 2008 Jan; 14(1):45-54. PubMed ID: 18212602
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 53. Extrapyramidal symptoms from intravenous haloperidol in the treatment of delirium.
    Blitzstein SM; Brandt GT
    Am J Psychiatry; 1997 Oct; 154(10):1474-5. PubMed ID: 9326840
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacopsychiatry and iatrogenic Parkinsonism.
    de Francisco CP; Portillio RG
    Adv Exp Med Biol; 1977; 90():191-6. PubMed ID: 930744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychological medicine. Schizophrenia and related paranoid psychoses.
    Kennedy PF
    Br Med J; 1975 May; 2(5965):257-60. PubMed ID: 236808
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug-induced parkinsonism.
    Lancet; 1985 Jan; 1(8420):113. PubMed ID: 2857014
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of Parkinson disease].
    Schlagmann C; Remien J
    Klin Wochenschr; 1986 Oct; 64(19):939-42. PubMed ID: 3491248
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
    Rajput AH; Rozdilsky B; Hornykiewicz O; Shannak K; Lee T; Seeman P
    Arch Neurol; 1982 Oct; 39(10):644-6. PubMed ID: 6127066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycine and clozapine: potential relevance for the treatment of Parkinson's disease.
    Maddaford S; Huot P
    Neurodegener Dis Manag; 2024; 14(3-4):47-49. PubMed ID: 38602420
    [No Abstract]   [Full Text] [Related]  

  • 60. Myoclonic and generalized tonic clonic seizures during combined treatment with low doses of clozapine and haloperidol.
    Haberfellner EM
    Eur Psychiatry; 2002 Mar; 17(1):55-6. PubMed ID: 11918994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.